BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1708359)

  • 1. Murine natural killer cells are fungicidal to Cryptococcus neoformans.
    Hidore MR; Nabavi N; Sonleitner F; Murphy JW
    Infect Immun; 1991 May; 59(5):1747-54. PubMed ID: 1708359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding interactions of murine natural killer cells with the fungal target Cryptococcus neoformans.
    Murphy JW; Hidore MR; Nabavi N
    Infect Immun; 1991 Apr; 59(4):1476-88. PubMed ID: 2004826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
    Nabavi N; Murphy JW
    Infect Immun; 1986 Feb; 51(2):556-62. PubMed ID: 3510982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine natural killer cell interactions with a fungal target, Cryptococcus neoformans.
    Hidore MR; Murphy JW
    Infect Immun; 1989 Jul; 57(7):1990-7. PubMed ID: 2659531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.
    Hidore MR; Murphy JW
    Infect Immun; 1986 Feb; 51(2):547-55. PubMed ID: 3510981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans.
    Hidore MR; Mislan TW; Murphy JW
    Infect Immun; 1991 Apr; 59(4):1489-99. PubMed ID: 2004827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural cellular resistance of beige mice against Cryptococcus neoformans.
    Hidore MR; Murphy JW
    J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.
    Miller MF; Mitchell TG; Storkus WJ; Dawson JR
    Infect Immun; 1990 Mar; 58(3):639-45. PubMed ID: 2407651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.
    Murphy JW; Hidore MR; Wong SC
    J Clin Invest; 1993 Apr; 91(4):1553-66. PubMed ID: 8473499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro binding of natural killer cells to Cryptococcus neoformans targets.
    Nabavi N; Murphy JW
    Infect Immun; 1985 Oct; 50(1):50-7. PubMed ID: 3899938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production.
    Murphy JW; Zhou A; Wong SC
    Infect Immun; 1997 Nov; 65(11):4564-71. PubMed ID: 9353034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-dependent cryptococcal microbicidal activity in NK cells requires PI3K-dependent ERK1/2 signaling.
    Wiseman JC; Ma LL; Marr KJ; Jones GJ; Mody CH
    J Immunol; 2007 May; 178(10):6456-64. PubMed ID: 17475875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans.
    Hidore MR; Nabavi N; Reynolds CW; Henkart PA; Murphy JW
    J Leukoc Biol; 1990 Jul; 48(1):15-26. PubMed ID: 2193078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.
    Kyei SK; Ogbomo H; Li S; Timm-McCann M; Xiang RF; Huston SM; Ganguly A; Colarusso P; Gill MJ; Mody CH
    mBio; 2016 Aug; 7(4):. PubMed ID: 27555306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for Cryptococcus neoformans bypasses LFA-1.
    Jones GJ; Wiseman JC; Marr KJ; Wei S; Djeu JY; Mody CH
    Int Immunol; 2009 Apr; 21(4):423-32. PubMed ID: 19261694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity.
    Marr KJ; Jones GJ; Zheng C; Huston SM; Timm-McCann M; Islam A; Berenger BM; Ma LL; Wiseman JC; Mody CH
    Infect Immun; 2009 Jun; 77(6):2436-46. PubMed ID: 19307209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of Cryptococcus neoformans from immunologically suppressed mice.
    Murphy JW
    Infect Immun; 1989 Jul; 57(7):1946-52. PubMed ID: 2499541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro interactions of immune lymphocytes and Cryptococcus neoformans.
    Fung PY; Murphy JW
    Infect Immun; 1982 Jun; 36(3):1128-38. PubMed ID: 7047393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18.
    Kawakami K; Koguchi Y; Qureshi MH; Yara S; Kinjo Y; Uezu K; Saito A
    Microbiol Immunol; 2000; 44(12):1043-50. PubMed ID: 11220678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.
    Levitz SM; Dupont MP; Smail EH
    Infect Immun; 1994 Jan; 62(1):194-202. PubMed ID: 8262627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.